FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/09/036541 [Registered on: 15/09/2021] Trial Registered Prospectively
Last Modified On: 18/12/2023
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   To study the treatment awareness and self medication behavior along with drugs prescribed in patients of long standing heart failure 
Scientific Title of Study   Evaluation of Awareness to Drug Treatment, Prescription Pattern & Self-medication practices in patients of Chronic Heart Failure 
Trial Acronym  CHF  
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Raakhi K tripathi  
Designation  Associate Professor 
Affiliation  Seth GS Medical college and KEM Hospital 
Address  Department of Pharmacology & Therapeutics, Seth G.S. medical College & K.E.M Hospital, Parel, Mumbai.

Mumbai
MAHARASHTRA
400012
India 
Phone    
Fax    
Email  lookon@rediffmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Sujeet Bhilwade 
Designation  Junior Resident Doctor 
Affiliation  Seth GS Medical college and KEM Hospital 
Address  Acharya Donde marg, parel, Mumbai

Mumbai
MAHARASHTRA
400012
India 
Phone    
Fax    
Email  sujeetbhilwade@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Sujeet Bhilwade 
Designation  Junior Resident Doctor 
Affiliation  Seth GS Medical college and KEM Hospital 
Address  Acharya Donde marg, parel, Mumbai

Mumbai
MAHARASHTRA
400012
India 
Phone    
Fax    
Email  sujeetbhilwade@gmail.com  
 
Source of Monetary or Material Support  
Seth GS Medical College and KEM Hospital, Mumbai 
 
Primary Sponsor  
Name  Dr Raakhi K Tripathi 
Address  Department of Pharmacology & Therapeutics, Seth GS Medical college & KEM Hospital, Parel, Mumbai. 400012  
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sujeet Bhilwade  Seth GS Medical College & KEM Hospital  Cardiology OPD, Department of Cardiology , CVTS building
Mumbai
MAHARASHTRA 
7276613562

sujeetbhilwade@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee-3, Seth GS Medical College & KEM Hospital, Paral, Mumbai 400012  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I509||Heart failure, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  1. Male or female patients with age >18 years, attending Cardiology OPD categorised for Chronic Heart failure with Grade I, II and III as per ACCF/AHA Guideline and willing to give consent.

2. Patients carrying treatment records prescribed at Cardiology OPD of KEM hospital, containing Chronic Heart Failure medication regimen for Grade I, II and III for at least 3 months and willing to give consent
 
 
ExclusionCriteria 
Details  1. Newly diagnosed and treatment-naive patients
2. Patients not willing to give informed consent.
3. Patients admitted in Cardiology IPD and emergency department.
4. Patients with a history of substance dependence or abuse.
5.Critically ill patients requiring urgent attention for medical problems
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Awareness of drug treatment in Chronic Heart Failure patients.  12 months 
 
Secondary Outcome  
Outcome  TimePoints 
Prescription Pattern of drugs used in the treatment of Chronic Heart Failure patients  12 months 
assessment of Self-medication practices in patients Chronic Heart Failure  12 months 
 
Target Sample Size   Total Sample Size="280"
Sample Size from India="280" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/09/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Closed to Recruitment of Participants 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  

HF is a complex clinical syndrome that results from any structural or functional impairment of ventricular filling or ejection of blood. In India, the burden of Heart failure appears to be high with an annual incidence of 600- 1.8 million with the prevalence ranging from 1.3 million to 4.6 million. The burden of Chronic Heart Failure is increasing to date there are no studies done in India related to treatment awareness about chronic Heart Failure in these patients, hence a cross-sectional, Observational study is planned to assess the awareness about the treatment of Chronic Heart Failure. The treatment of chronic illness commonly includes the long-term use of pharmacotherapy that led to variability in the prescription pattern. The use of some OTC medications such as NSAIDs and nasal decongestants by individuals with heart failure increases the possibility of exacerbation of Heart failure. No study regarding Self-medication practices in chronic Heart failure patients was done in India. Hence, we would like to undertake this study in patients attending the cardiology OPD, with 11 items pre-validated questionnaire for treatment awareness and 12 items pre-validated questionnaire for self-medication practices. The data collected will be analyzed using descriptive statistics.

 

 
Close